Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07738315 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Elemene Liposomes in Endometrial Cancer

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this clinical trial is to learn if Elemene Liposomes, combined with carboplatin and paclitaxel (TC) chemotherapy can improve prognosis in patients with advanced or recurrent endometrial cancer. The main question it aims to answer is: Does adding Elemene Liposomes to TC chemotherapy can delay disease recurrence time in patients with advanced or recurrent endometrial carcinoma. Researchers will compare Elemene Liposomes +TC chemotherapy to TC chemotherapy alone to see if Elemene Liposomes, combined with carboplatin and paclitaxel (TC) chemotherapy can improve prognosis in patients with advanced or recurrent endometrial cancer. Participants will: * Receive TC Chemotherapy every 21 days, for a total of 6 cycles. * Take intravenous infusion of Elemene liposome injection every day from day 1 to day 7 of cycle 1 and 2, and take oral Elemene emulsion twice every day, from day 1 to day 14 of cycles 3 to cycle 6. (no intravenous or oral Elemene will be given in comparison group) * Visit the clinic for checkups and tests once every 21 days during treatment and every 3 to 12 months after the treatment is completed.
Trial Details
NCT Number NCT07738315
Lead Sponsor Women's Hospital School Of Medicine Zhejiang University
Collaborators: Beijing Friendship Hospital, The First Affiliated Hospital of Zhengzhou University, Second Affiliated Hospital of Wenzhou Medical University, Second Affiliated Hospital, Zhejiang University, School of Medicine, Jiaxing Maternity and Child Health Care Hospital, Jiangxi Maternal and Child Health Hospital, Fujian Maternity and Child Health Hospital, Ningbo Women & Children's Hospital
Conditions
(from sponsor)		 Endometrial Carcinoma
Related terms Endometrial Neoplasms
Enrollment 212 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov